TRENDING :  Market Movers  |  Top 50   SPY (0.51%)    XOP (0.56%)    UGAZ (-16.07%)    TVIX (-1.69%)    TSLA (-0.05%)    TQQQ (2.52%)    SPX (0.51%)    SLG (-2.77%)    NTES (3.86%)    NBEV (10.48%)    MU (2.33%)    MA (1.29%)    GS (-0.06%)    FB (1.71%)    EWC (1.11%)    BTCUSD (%)    BOIL (-10.06%)    BIG (-0.37%)    ATVI (0.52%)    AMZN (1.24%)

 VKTX - Viking Therapeutics

$9.81 (3.49%)

Next Earnings

3/6/2019

AMC



Analyst Rating

CompanyAnalyst NamePT ActionActionRatingTargetDate
B. Riley FBRAnnouncesInitiates Coverage OnBuy$16.0012:00 AM
Raymond JamesUpgradesStrong Buy$0.0011/19/18
Raymond JamesSteven SeedhouseRaisesMaintainsOutperform$43.0009/19/18
H.C. WainwrightJoseph PantginisRaisesMaintainsBuy$28.0009/18/18
SunTrust Robinson HumphreyAnnouncesInitiates Coverage OnBuy$14.0007/20/18
Raymond JamesAnnouncesInitiates Coverage OnOutperform$15.0006/28/18
H.C. WainwrightJoseph PantginisRaisesReiteratesBuy$15.0006/01/18
William BlairInitiates Coverage OnOutperform$0.0004/30/18
H.C. WainwrightJoseph PantginisAnnouncesAssumesBuy$11.0003/26/18

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $VKTX

TRENDING ARTICLES



3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019

12:00 AM
Developing new drugs is a risky business that hasn t been kind to these three biotechs or their shareholders lately But despite recent tumbling stock prices all of these companies have a chance to bounce back in 2019 Of course some of these biotech stocks have a better chance

Why Viking Therapeutics Stock Continued to Slide in November

12/10/18
What happened Viking Therapeutics NASDAQ VKTX a clinical stage biotech developing drugs for endocrine and metabolic disorders has seen its shares hit the skids in the back end of 2018 Despite a double digit drop in its share price in October for instance Viking s stock

Here's Why Madrigal Pharmaceuticals Fell 39.4% in November

12/08/18
What happened Shares of Madrigal 160 Pharmaceuticals NASDAQ MDGL 160 a clinical stage 160 biotechnology company fell 39 4 in November according to data from S amp P Global Market Intelligence Madrigal presented impressive clinical trial results for its

Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking Therapeutics, Inc.

11/14/18
If you re like most people you ve never heard of non alcoholic steatohepatitis NASH even though the epidemic threatens the lives of perhaps 20 million Americans right now There aren t any available treatments that stop immune systems from damaging fatty livers but

Health Care Sector Update for 11/13/2018: ABBV,VKTX,CRON,CRON.TO,VLRX

11/13/18
Top Health Care StocksTop Health Care Stocks JNJ 0 56 JNJ 0 56 PFE 1 56 PFE 1 56 ABT 1 83 ABT 1 83 MRK 0 41 MRK 0 41 AMGN 0 07 AMGN 0 07 Health care stocks continue to trend lower today including a slightly more than 0 6 decline for the NYSE Health Care Index in recent trade

Health Care Sector Update for 11/13/2018: CRON,VKTX,VLRX

11/13/18
Top Health Care StocksTop Health Care Stocks JNJ 0 73 JNJ 0 73 PFE 1 33 PFE 1 33 ABT 0 77 ABT 0 77 MRK 0 66 MRK 0 66 AMGN 0 03 AMGN 0 03 Health care stocks were trending lower including a slightly more than 0 4 decline for the NYSE Health Care Index in recent trade Also shares

Health Care Sector Update for 11/13/2018: VKTX, CRON, VLRX, JNJ, PFE, ABT, MRK, AMGN

11/13/18
Top Health Care Stocks Top Health Care Stocks JNJ FlatJNJ Flat PFE 0 18 PFE 0 18 ABT 0 40 ABT 0 40 MRK 0 42 MRK 0 42 AMGN FlatAMGN Flat Health care stocks were flat to higher early Tuesday Health care stocks were flat to higher early Tuesday Stocks moving on news include

Why Viking Therapeutics Stock Is Bolting Higher Today

11/13/18
What happened Shares of the clinical stage biotech Viking Therapeutics NASDAQ VKTX rose by as much as 15 in pre market trading today Why are investors bidding up this stock today The big news is that Viking presented updated data for its 160 nonalcoholic